Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
5/1/2024 | $26.00 | Buy | Craig Hallum | |
12/29/2023 | $25.00 → $21.00 | Buy | BTIG Research | |
12/1/2023 | $52.00 | Neutral | Susquehanna | |
11/28/2023 | $62.00 | Overweight | CapitalOne | |
8/21/2023 | $18.00 | Equal-Weight → Overweight | Stephens | |
7/5/2023 | $64.00 | Buy | Citigroup | |
5/16/2023 | Outperform → Mkt Perform | Raymond James | ||
5/9/2023 | $25.00 | Neutral → Buy | BTIG Research |
S-8 POS - Noble Corp plc (0001895262) (Filer)
8-K - Noble Corp plc (0001895262) (Filer)
8-K - Noble Corp plc (0001895262) (Filer)
Craig Hallum resumed coverage of NeoGenomics with a rating of Buy and set a new price target of $26.00
BTIG Research reiterated coverage of NeoGenomics with a rating of Buy and set a new price target of $21.00 from $25.00 previously
Susquehanna resumed coverage of Noble Corporation with a rating of Neutral and set a new price target of $52.00
SUGAR LAND, Texas, Aug. 30, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE:NOBLE, NYSE:NE) and Diamond Offshore Drilling, Inc. ("Diamond Offshore") (NYSE:DO) announced today the receipt of clearance from the Australia Competition & Consumer Commission, in relation to the pending transaction between Noble and Diamond Offshore, which is the final required regulatory approval for the transaction. The parties expect to close the transaction on Wednesday September 4th, 2024. About Noble Corporation plcNoble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile, and technically advanced fleets in the of
Announced acquisition of Diamond Offshore Drilling, Inc. ("Diamond"), bolstering a leading position in deepwater; transaction expected to close by Q1 2025.Q2 Net Income of $195 million, Diluted Earnings Per Share of $1.34, Adjusted EBITDA of $271 million, net cash provided by operating activities of $107 million, and Free Cash Flow of $(26) million.As previously announced, Q3 dividend increased to $0.50 per share, establishing the current highest dividend payout in U.S. oilfield services sector.Guidance for Full Year 2024 Adjusted EBITDA narrowed to $950-$1,000 million (from $925-$1,025 million).SUGAR LAND, Texas, July 31, 2024 /PRNewswire/ -- Noble Corporation plc (NYSE:NE, CSE:NOBLE, ", No
Second Quarter Revenue Increased 12% to $165 Million Raising Revenue Guidance $655 to $667 Million and Adjusted EBITDA to $33 to $37 Million NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services company, today announced its second-quarter results for the period ended June 30, 2024. Second Quarter 2024 Highlights As Compared To Second Quarter 2023 Consolidated revenue increased 12% to $165 million Clinical Services revenue increased 15% to $141 million Advanced Diagnostics revenue decreased 3% to $23 million Net loss decreased 23% to $19 million Adjusted EBITDA increased 630% to positive $11 million "The second quart
NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will present three studies at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, September 13-17 (booth #438). NeoGenomics' data offers key insights into circulating tumor DNA (ctDNA) analysis and next-generation sequencing (NGS), focusing on their role in early diagnosis and treatment optimization. "Emerging technologies leveraging ctDNA and NGS are increasing our ability to identify cancers in high-risk patients, which was previously beyond reach," said Dr. Nathan Montgomery, Vice President of Medical Services at NeoGenomics. "Collectively, our findings demonstrate the potential
SUGAR LAND, Texas, Sept. 4, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble", the "Company") (CSE:NOBLE, NYSE:NE) today announces the completion of its acquisition of Diamond Offshore Drilling, Inc ("Diamond"). This transaction enhances Noble's position as a leading offshore driller, creating the largest fleet of 7th generation dual-BOP drillships in the industry, and adding approximately $2 billion of backlog. Following completion of the acquisition of Diamond, the Company's board of directors has appointed Patrice Douglas from the Diamond board of directors to serve as a new director of Noble. Noble has filed a form 8-K regarding the completion of the acquisition with the U.S. Securit
SUGAR LAND, Texas, Aug. 31, 2024 /PRNewswire/ -- Noble Corporation plc ("Noble") (NYSE:NE, CSE:NOBLE) today announces changes to its share capital. During the month of August, Noble has repurchased approximately USD 44.2 million of A ordinary shares under its previously announced share repurchase plan at a weighted average price of approximately USD 37.90 per A ordinary share. These shares, repurchased during the last week of August, are expected to be cancelled in September (thus their cancellation is not yet reflected in the outstanding share count total enumerated below). During the period since July 31, 2024, 120,506 new A ordinary shares each with a nominal value of USD 0.00001 have be
PRESS RELEASE - 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Mechelen, Belgium 10 June 2024 – Biocartis NV (the ‘Company' or ‘Biocartis'), an innovative molecular diagnostics company, is pleased to announce the appointment of Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as Vice President Global Marketing. Gina Wallar, PhD as Chief Business Officer: Gina Wallar was appointed as Biocartis' Chief Business Officer on 15 April 2024 and will be responsible for Biocartis' business development and partnering initiatives, as well as US commercialization. Dr. Wallar has more than 20 year
FT. MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.The Board has elected three new independent board members to join the board effective June 29, 2023. Elizabeth Floegel, Chief Information & Digital Officer of Numotion, a complex rehabilitation technology provider, will be a member of the Audit & Finance and Compliance Committees. Neil Gunn, former Chief Executive Officer of IDbyDNA, a developer of metagenomic technology for infectious disease testing and pathogen surveillance which was
SUGAR LAND, Texas, May 3, 2023 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE:NOBLE, NYSE:NE) announces the resolutions adopted at its 2023 annual general meeting of shareholders held on May 2, 2023. The following resolutions were adopted: Robert W. Eifler, Claus V. Hemmingsen, Alan J. Hirshberg, Kristin H. Holth, Alastair Maxwell, Ann D. Pickard and Charles M. Sledge were re-elected as directors of Noble. After the annual general meeting of shareholders, the board of directors convened and elected Charles M. Sledge as chairman.Ratification of the appointment of PricewaterhouseCoopers LLP (US) as Independent Registered Public Accounting Firm for fiscal year 2023.Re-appointment of Price
SC 13D/A - Noble Corp plc (0001895262) (Subject)
SC 13D/A - Noble Corp plc (0001895262) (Subject)
SC 13G - NEOGENOMICS INC (0001077183) (Subject)
3 - Noble Corp plc (0001895262) (Issuer)
4 - NEOGENOMICS INC (0001077183) (Issuer)
4 - NEOGENOMICS INC (0001077183) (Issuer)
-Reuters
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform. Noble Corporation The Trade: Noble Corporation plc (NYSE:NE) 10% owner APMH Invest A/S acquired a total of 638,018 shares at
Susquehanna analyst Charles Minervino maintains Noble Corp (NYSE:NE) with a Neutral and lowers the price target from $49 to $47.
4 - Noble Corp plc (0001895262) (Issuer)
4 - Noble Corp plc (0001895262) (Issuer)
4 - Noble Corp plc (0001895262) (Issuer)